drjobs PhD student Decoding Epigenetics in T cells to Improve Cancer Therapy

PhD student Decoding Epigenetics in T cells to Improve Cancer Therapy

Employer Active

1 Vacancy
drjobs

Job Alert

You will be updated with latest job alerts via email
Valid email field required
Send jobs
Send me jobs like this
drjobs

Job Alert

You will be updated with latest job alerts via email

Valid email field required
Send jobs
Job Location drjobs

Amsterdam - Netherlands

Monthly Salary drjobs

EUR 3665 - 4450

Vacancy

1 Vacancy

Job Description

Job description

The group of Fred van Leeuwen is looking for a PhD candidate to join our team working on mechanisms and functions of epigenetic pathways in cancer development and this project funded by KWF you will study how targeting an epigenetic writer protein called DOT1L reprograms cytotoxic T cells. T cells are a crucial players in anti-tumor responses but tuning their activity remains a challenge. By understanding the epigenetic mechanisms by which DOT1L works we hope to ultimately strengthen T cells so they can fight cancer cells more effectively.

CD8 T cells play a central role in cancer immunotherapy. We recently observed that inactivation of the epigenetic writer DOT1L in CD8 T cells leads enhanced cytotoxic activity towards tumor cells in vitro. DOT1L is known to methylate histones at position H3K79 in gene bodies of transcribed genes. However if and how this epigenetic marking influences cytotoxic behavior is still poorly understood. This knowledge gap hinders developing rational approaches to target the DOT1L-controlled program with the aim to further improve T cell therapy.

In this research project you will:

Why the Netherlands Cancer Institute

Netherlands Cancer Institute (NKI) is a dynamic comprehensive cancer center accommodating over 55 research groups and many state-of-the-art core facilities including imaging flow cytometry proteomics genomics and screening. At the Netherlands Cancer Institute we have a shared goal: providing the best care for every patient and every type of cancer. Quite a lot but not impossible. Here science and health care join forces towards innovation. We keep finding new ways to help people facing cancer on a global scale.

Job requirements

If the challenge appeals to you and you recognize yourself in the conditions below we would like to invite you to apply. We are looking for a colleague who meets the following criteria:

Your development opportunities and employment conditions

The basis for your employment conditions is in accordance with the CLA Hospitals. You will receive from us:

Interested

We are curious about your talent! Will you be the one to make a difference in the world of cancer care and research You can apply by clicking the apply (solliciteer) button at the top of the page. Include in your application:

Ensure that your references information and an overview of your grades are attached together with your application letter or CV as there is no option to submit them separately.

For questions about the position please contact Fred van Leeuwen via .

Our group is part of the Division of Gene regulation which focuses on (epigenetic) mechanisms of genome-organization and gene transcription. We work in close collaboration with the Division of Molecular Oncology and Immunology for complementary expertise on immune cell biology genetic modification and phenotyping of T cells and T cell therapy.

This vacancy is open for applications until November 1st 2025. Qualified candidates may be invited prior to the application deadline.

Employment Type

Full-Time

Report This Job
Disclaimer: Drjobpro.com is only a platform that connects job seekers and employers. Applicants are advised to conduct their own independent research into the credentials of the prospective employer.We always make certain that our clients do not endorse any request for money payments, thus we advise against sharing any personal or bank-related information with any third party. If you suspect fraud or malpractice, please contact us via contact us page.